Last reviewed · How we verify

NCT04651556

Intraperitoneal Magnesium Sulphate and Bupivacaine Versus Intravenous Analgesia in Laparoscopic Surgeries in Pediatrics

Completed Phase 4 Last updated 8 December 2020
What this trial tests

Phase 4 trial testing Magnesium Sulfate & bupivacaine in Intraperitoneal Magnesium Sulphate in Laparoscope in Pediatrics in 66 participants. Completed in 15 November 2020.

Timeline
4 April 2019
Primary endpoint
15 June 2020
15 November 2020

Quick facts

Lead sponsorMenoufia University
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment66
Start date4 April 2019
Primary completion15 June 2020
Estimated completion15 November 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Menoufia University

Who can join

Adults 1 to 12, any sex, with Intraperitoneal Magnesium Sulphate in Laparoscope in Pediatrics. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators are going to study the analgesic efficacy of intraperitoneal instillation of a combination of Magnesium sulphate with bupivacaine versus ordinary used parenteral analgesics for pain relief after laparoscopic surgeries in pediatrics.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Menoufia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04651556.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing